Live from Stage 4 | Episode # 3 | 10/07/2025 | Interview with Dr. Gloria Echeverria, PhD

Guest

Dr. Gloria Vittone Echeverria, PhD

An assistant professor at Baylor College of Medicine and a leading cancer researcher specializing in triple-negative breast cancer (TNBC). She leads the Echeverria Lab, which focuses on understanding how these cancers resist chemotherapy and metastasize to other parts of the body. 

Listen to full episode :

Quick Summary

Takeaways

  • Dr. Gloria Echevarria’s lab at Baylor College of Medicine focuses on understanding and developing new treatments for triple negative breast cancer, a particularly aggressive and hard-to-treat subtype.

  • Federal funding cuts and uncertainty are significantly impacting research labs, leading to fewer opportunities for young scientists and forcing labs to scale back or pause important projects.

  • Diversifying funding sources beyond federal grants is now essential for research labs to survive and continue their work.

  • Despite the challenges, ongoing scientific collaboration and innovation are leading to promising breakthroughs, and Dr. Echevarria remains hopeful about the future of cancer research.

Resources Mentioned

  • ✅ Important article — Perspective of a breast cancer researcher facing drastic cuts to academic research funding and disruptions to critical grant review processes, highlighting the devastating impact on lifesaving biomedical research. Read: this link (Must-read)

Previous
Previous

MBC Insiders: MBC Awareness Day and More

Next
Next

Future at Risk: Protecting Research, Protecting Lives